Table 1.
Clinicopathologic features | n = 86 | miR‐497 expression | P | |
---|---|---|---|---|
Low | High | |||
Age (year) | ||||
<50 | 25 | 14 | 11 | 0.476 |
≥50 | 61 | 29 | 32 | |
Sex | ||||
Male | 68 | 35 | 33 | 0.596 |
Female | 18 | 8 | 10 | |
HBV | ||||
Absent | 24 | 10 | 14 | 0.336 |
Present | 62 | 33 | 29 | |
Serum AFP level (ng·mL−1) | ||||
<20 | 20 | 6 | 19 | 0.002* |
≥20 | 66 | 37 | 24 | |
Tumor size (cm) | ||||
<5 | 27 | 8 | 19 | 0.011* |
≥5 | 59 | 35 | 24 | |
No. of tumor nodules | ||||
1 | 60 | 29 | 31 | 0.639 |
≥2 | 26 | 14 | 12 | |
Cirrhosis | ||||
Absent | 31 | 13 | 18 | 0.261 |
Present | 55 | 30 | 25 | |
Venous infiltration | ||||
Absent | 46 | 19 | 27 | 0.084 |
Present | 40 | 24 | 16 | |
Edmondson–Steiner grading | ||||
I + II | 51 | 20 | 31 | 0.016* |
III + IV | 35 | 23 | 12 | |
TNM tumor stage | ||||
I + II | 67 | 28 | 39 | 0.004* |
III + IV | 19 | 15 | 4 |
HCC, hepatocellular carcinoma; HBV, hepatitis B virus; AFP, alpha‐fetoprotein; TNM, tumor–node–metastasis.
*Statistically significant.